The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease

被引:424
作者
Cookson, Mark R. [1 ]
机构
[1] NIA, Neurogenet Lab, NIH, Bethesda, MD 20982 USA
基金
美国国家卫生研究院;
关键词
AUTOSOMAL-DOMINANT PARKINSONISM; ALPHA-SYNUCLEIN; LEUCINE-RICH-REPEAT-KINASE-2; LRRK2; CYTOPLASMIC LOCALIZATION; 14-3-3; BINDING; ROC DOMAIN; MUTATIONS; PROTEIN; PHOSPHORYLATION; GENE;
D O I
10.1038/nrn2935
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component. Here, I discuss how mutations in a large complex gene-leucine-rich repeat kinase 2 (LRRK2) - affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically a-synuclein and tau. These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.
引用
收藏
页码:791 / 797
页数:7
相关论文
共 74 条
  • [71] Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice
    Tong, Youren
    Yamaguchi, Hiroo
    Giaime, Emilie
    Boyle, Scott
    Kopan, Raphael
    Kelleher, Raymond J., III
    Shen, Jie
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (21) : 9879 - 9884
  • [72] Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
    West, AB
    Moore, DJ
    Biskup, S
    Bugayenko, A
    Smith, WW
    Ross, CA
    Dawson, VL
    Dawson, TM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (46) : 16842 - 16847
  • [73] Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
    Wider, Christian
    Dickson, Dennis W.
    Wszolek, Zbigniew K.
    [J]. NEURODEGENERATIVE DISEASES, 2010, 7 (1-3) : 175 - 179
  • [74] Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
    Zimprich, A
    Biskup, S
    Leitner, P
    Lichtner, P
    Farrer, M
    Lincoln, S
    Kachergus, J
    Hulihan, M
    Uitti, RJ
    Calne, DB
    Stoessl, AJ
    Pfeiffer, RF
    Patenge, N
    Carbajal, IC
    Vieregge, P
    Asmus, F
    Müller-Myhsok, B
    Dickson, DW
    Meitinger, T
    Strom, TM
    Wszolek, ZK
    Gasser, T
    [J]. NEURON, 2004, 44 (04) : 601 - 607